Potent inhibition of human and rat 17β-hydroxysteroid dehydrogenase 1 by curcuminoids and the metabolites: 3D QSAR and in silico docking analysis

References

• S.C. Gupta, B. Sung, J.H. Kim, S. Prasad, S. Li, and B.B. Aggarwal, Multitargeting by turmeric, the golden spice: From kitchen to clinic, Mol. Nutr. Food Res. 57 (2013), pp. 1510–1528. doi:10.1002/mnfr.201100741.
   PubMed Web of Science ®Google Scholar
• K.M. Nelson, J.L. Dahlin, J. Bisson, J. Graham, G.F. Pauli, and M.A. Walters, The essential medicinal chemistry of curcumin, J. Med. Chem. 60 (2017), pp. 1620–1637. doi:10.1021/acs.jmedchem.6b00975.
   PubMed Web of Science ®Google Scholar
• M.E. Braga, P.F. Leal, J.E. Carvalho, and M.A. Meireles, Comparison of yield, composition, and antioxidant activity of turmeric (Curcuma longa L.) extracts obtained using various techniques, J. Agric. Food Chem. 51 (2003), pp. 6604–6611. doi:10.1021/jf0345550.
   PubMed Web of Science ®Google Scholar
• L. Nardo, A. Andreoni, M. Masson, T. Haukvik, and H.H. Tønnesen, Studies on curcumin and curcuminoids. XXXIX. Photophysical properties of bisdemethoxycurcumin, J. Fluor. 21 (2010), pp. 627–635. doi:10.1007/s10895-010-0750-x.
   PubMed Web of Science ®Google Scholar
• B.B. Aggarwal, W. Yuan, S. Li, and S.C. Gupta, Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: Identification of novel components of turmeric, Mol. Nutr. Food Res. 57 (2013), pp. 1529–1542. doi:10.1002/mnfr.201200838.
   PubMed Web of Science ®Google Scholar
• A. Pandey, M. Chaturvedi, S. Mishra, P. Kumar, P. Somvanshi, and R. Chaturvedi, Reductive metabolites of curcumin and their therapeutic effects, Heliyon 6 (2020), pp. e05469. doi:10.1016/j.heliyon.2020.e05469.
   PubMed Web of Science ®Google Scholar
• H. Kou, L. Huang, M. Jin, Q. He, R. Zhang, and J. Ma, Effect of curcumin on rheumatoid arthritis: A systematic review and meta-analysis, Front. Immunol. 14 (2023), pp. 1121655. doi:10.3389/fimmu.2023.1121655.
   PubMed Web of Science ®Google Scholar
• S. Hassanizadeh, M. Shojaei, M. Bagherniya, A.N. Orekhov, and A. Sahebkar, Effect of nano-curcumin on various diseases: A comprehensive review of clinical trials, Biofactors 49 (2023), pp. 512–533. doi:10.1002/biof.1932.
   PubMed Web of Science ®Google Scholar
• Q. Yu, Y. Liu, Y. Wu, and Y. Chen, Dihydrocurcumin ameliorates the lipid accumulation, oxidative stress and insulin resistance in oleic acid-induced L02 and HepG2 cells, Biomed. Pharmacother. 103 (2018), pp. 1327–1336. doi:10.1016/j.biopha.2018.04.143.
   PubMed Web of Science ®Google Scholar
• O.A. Ahmed Hamdi, K. Awang, A.H. Hadi, D.R. Syamsir, and S.W. Ng, Curcumenol from Curcuma zedoaria: A second monoclinic modification, Acta Crystallogr. Sect. E: Struct. Rep. Online 66 (2010), pp. o2844. doi:10.1107/S1600536810040559.
   PubMedGoogle Scholar
• M. Aspollah Sukari, T.S. Wah, S.M. Saad, N.Y. Rashid, M. Rahmani, N.H. Lajis, and T.Y. Hin, Bioactive sesquiterpenes from Curcuma ochrorhiza and Curcuma heyneana, Nat. Prod. Res. 24 (2010), pp. 838–845. doi:10.1080/14786410903052951.
   PubMed Web of Science ®Google Scholar
• Y.H. Yu, H.J. Zhang, F. Yang, L. Xu, and H. Liu, Curcumol, a major terpenoid from Curcumae Rhizoma, attenuates human uterine leiomyoma cell development via the p38MAPK/NF-kappaB pathway, J. Ethnopharmacol. 310 (2023), pp. 116311. doi:10.1016/j.jep.2023.116311.
   PubMed Web of Science ®Google Scholar
• G.X. Hu, G. Liang, Y. Chu, X. Li, Q.Q. Lian, H. Lin, Y. He, Y. Huang, D.O. Hardy, and R.S. Ge, Curcumin derivatives inhibit testicular 17β-hydroxysteroid dehydrogenase 3, Bioorg. Med. Chem. Lett. 20 (2010), pp. 2549–2551. doi:10.1016/j.bmcl.2010.02.089.
   PubMed Web of Science ®Google Scholar
• N. Suphrom, G. Pumthong, N. Khorana, N. Waranuch, N. Limpeanchob, and K. Ingkaninan, Anti-androgenic effect of sesquiterpenes isolated from the rhizomes of Curcuma aeruginosa roxb, Fitoterapia 83 (2012), pp. 864–871. doi:10.1016/j.fitote.2012.03.017.
   PubMed Web of Science ®Google Scholar
• J. Sang, J. Chu, X. Zhao, H. Quan, Z. Ji, S. Wang, Y. Tang, Z. Hu, H. Li, L. Li, and R.S. Ge, Curcuminoids inhibit human and rat placental 3beta-hydroxysteroid dehydrogenases: Structure-activity relationship and in silico docking analysis, J. Ethnopharmacol. 305 (2023), pp. 116051. doi:10.1016/j.jep.2022.116051.
   PubMed Web of Science ®Google Scholar
• X. Qiao, L. Ye, J. Lu, C. Pan, Q. Fei, Y. Zhu, H. Li, H. Lin, R.S. Ge, and Y. Wang, Curcumin analogues exert potent inhibition on human and rat gonadal 3β-hydroxysteroid dehydrogenases as potential therapeutic agents: Structure-activity relationship and in silico docking, J. Enz. Inhib. Med. Chem. 38 (2023), pp. 2205052. doi:10.1080/14756366.2023.2205052.
   PubMed Web of Science ®Google Scholar
• G.X. Hu, H. Lin, Q.Q. Lian, S.H. Zhou, J. Guo, H.Y. Zhou, Y. Chu, and R.S. Ge, Curcumin as a potent and selective inhibitor of 11β-hydroxysteroid dehydrogenase 1: Improving lipid profiles in high-fat-diet-treated rats, PLOS ONE 8 (2013), pp. e49976. doi:10.1371/journal.pone.0049976.
   PubMed Web of Science ®Google Scholar
• W. He, M. Gauri, T. Li, R. Wang, and S.X. Lin, Current knowledge of the multifunctional 17beta-hydroxysteroid dehydrogenase type, Gene 588 (2016), pp. 54–61. doi:10.1016/j.gene.2016.04.031.
   PubMed Web of Science ®Google Scholar
• S. Chen, S. Wang, J. Zheng, H. Lu, H. Chen, Y. Tang, N. Wang, Y. Zhu, Y. Wang, P. Duan, and R.S. Ge, Bisphenol analogues inhibit human and rat 17beta-hydroxysteroid dehydrogenase 1: 3D-quantitative structure-activity relationship (3D-QSAR) and in silico docking analysis, Food Chem. Toxicol. 181 (2023), pp. 114052. doi:10.1016/j.fct.2023.114052.
   PubMed Web of Science ®Google Scholar
• R. Breton, D. Housset, C. Mazza, and J.C. Fontecilla-Camps, The structure of a complex of human 17β-hydroxysteroid dehydrogenase with estradiol and NADP+ identifies two principal targets for the design of inhibitors, Structure 4 (1996), pp. 905–915. doi:10.1016/s0969-2126(96)00098-6.
   PubMed Web of Science ®Google Scholar
• W. Qiu, R.L. Campbell, A. Gangloff, P. Dupuis, R.P. Boivin, M.R. Tremblay, D. Poirier, and S.X. Lin, A concerted, rational design of type 1 17β-hydroxysteroid dehydrogenase inhibitors: Estradiol-adenosine hybrids with high affinity, Faseb J. 16 (2002), pp. 1829–1831. doi:10.1096/fj.02-0026fje.
   PubMed Web of Science ®Google Scholar
• D. Van Der Spoel, E. Lindahl, B. Hess, G. Groenhof, A.E. Mark, and H.J. Berendsen, GROMACS: Fast, flexible, and free, J. Comput. Chem. 26 (2005), pp. 1701–1718. doi:10.1002/jcc.20291.
   PubMed Web of Science ®Google Scholar
• L. Narciso, F. Ietta, R. Romagnoli, L. Paulesu, A. Mantovani, and S. Tait, Effects of bisphenol a on endogenous retroviral envelopes expression and trophoblast fusion in BeWo cells, Reprod. Toxicol. 89 (2019), pp. 35–44. doi:10.1016/j.reprotox.2019.07.001.
   PubMed Web of Science ®Google Scholar
• J.J. Irwin and B.K. Shoichet, ZINC–a free database of commercially available compounds for virtual screening, J. Chem. Inf. Model. 45 (2005), pp. 177–182. doi:10.1021/ci049714.
   PubMed Web of Science ®Google Scholar
• G. Xiong, Z. Wu, J. Yi, L. Fu, Z. Yang, C. Hsieh, M. Yin, X. Zeng, C. Wu, A. Lu, X. Chen, T. Hou, and D. Cao, ADMETlab 2.0: An integrated online platform for accurate and comprehensive predictions of ADMET properties, Nucleic Acids Res. 49 (2021), pp. W5–W1. doi:10.1093/nar/gkab255.
   PubMed Web of Science ®Google Scholar
• R.T. Engeli, S.R. Rohrer, A. Vuorinen, S. Herdlinger, T. Kaserer, S. Leugger, D. Schuster, and A. Odermatt, Interference of paraben compounds with estrogen metabolism by inhibition of 17β-hydroxysteroid dehydrogenases, Int. J. Mol. Sci. 18 (2017), pp. 2007. doi:10.3390/ijms18092007.
   PubMed Web of Science ®Google Scholar
• A. Gangloff, A. Garneau, Y.W. Huang, F. Yang, and S.X. Lin, Human oestrogenic 17β-hydroxysteroid dehydrogenase specificity: Enzyme regulation through an NADPH-dependent substrate inhibition towards the highly specific oestrone reduction, Biochem. J. 356 (2001), pp. 269–276. doi:10.1042/0264-6021:3560269.
   PubMed Web of Science ®Google Scholar
• Y. Zhang, Y. Huo, W. He, S. Liu, H. Li, and L. Li, Visfatin is regulated by interleukin6 and affected by the PPARgamma pathway in BeWo cells, Mol. Med. Rep. 19 (2019), pp. 400–406. doi:10.3892/mmr.2018.9671.
   PubMedGoogle Scholar
• E. Pedernera, F. Morales-Vasquez, M.J. Gomora, M.A. Almaraz, E. Mena, D. Perez-Montiel, E. Rendon, H. Lopez-Basave, J. Maldonado-Cubas, and C. Mendez, 17β-hydroxysteroid dehydrogenase type 1 improves survival in serous epithelial ovarian tumors, Endocr. Connect. 12 (2023), pp. e230315. doi:10.1530/EC-23-0315.
   PubMed Web of Science ®Google Scholar
• D. Poirier, Contribution to the development of inhibitors of 17β-hydroxysteroid dehydrogenase types 1 and 7: Key tools for studying and treating estrogen-dependent diseases, J. Steroid Biochem. Mol. Biol. 125 (2011), pp. 83–94. doi:10.1016/j.jsbmb.2010.12.007.
   PubMed Web of Science ®Google Scholar
• J.A. Aka, M. Mazumdar, and S.X. Lin, Reductive 17β-hydroxysteroid dehydrogenases in the sulfatase pathway: Critical in the cell proliferation of breast cancer, Mol. Cell. Endocrinol. 301 (2009), pp. 183–190. doi:10.1016/j.mce.2008.10.042.
   PubMed Web of Science ®Google Scholar
• J.M. Day, H.J. Tutill, A. Purohit, and M.J. Reed, Design and validation of specific inhibitors of 17 -hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis, Endocr. Relat. Cancer 15 (2008), pp. 665–692. doi:10.1677/ERC-08-0042.
   PubMed Web of Science ®Google Scholar
• J. Liu, Q. Wang, E. Omari-Siaw, M. Adu-Frimpong, J. Liu, X. Xu, and J. Yu, Enhanced oral bioavailability of bisdemethoxycurcumin-loaded self-microemulsifying drug delivery system: Formulation design, in vitro and in vivo evaluation, Int. J. Pharm. 590 (2020), pp. 119887. doi:10.1016/j.ijpharm.2020.119887.
   PubMed Web of Science ®Google Scholar